IRON OVERLOAD
Clinical trials for IRON OVERLOAD explained in plain language.
Never miss a new study
Get alerted when new IRON OVERLOAD trials appear
Sign up with your email to follow new studies for IRON OVERLOAD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an iron scavenger slow ALS? small study tests safety
Disease control CompletedThis study tested whether a drug called deferiprone, which removes excess iron from the body, is safe and can slow the progression of ALS (Lou Gehrig's disease). Researchers believe too much iron in the brain may damage nerve cells. Twenty-three adults with ALS took the drug for …
Matched conditions: IRON OVERLOAD
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
Lab study explores iron chelation in Parkinson's and ALS cells
Knowledge-focused CompletedThis study used blood cells from 90 people with Parkinson's disease, ALS, or healthy volunteers to see how the drug deferiprone affects cell stress and energy. The goal was to learn more about the disease process, not to treat patients. Results may guide future research.
Matched conditions: IRON OVERLOAD
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 17, 2026 03:43 UTC